Drug Trial Radar · NCT00234897
Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis
Last checked: Nov 19, 2026Latest source record: Aug 29, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,938
Actual
Start
Aug 2004
Primary completion
Not stated
Sponsor
- Lead sponsor
- AbbottIndustry
- Sponsor type
- Industry
- First posted
- Oct 10, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment
Conditions
- Rheumatoid Arthritis
Interventions
adalimumabDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient reported outcomes, clinical response indicators.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Global Medical Information - Abbott
North Chicago, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.